Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001344236 | SCV001538276 | benign | Greig cephalopolysyndactyly syndrome; Pallister-Hall syndrome | 2024-05-22 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002493764 | SCV002803220 | uncertain significance | Greig cephalopolysyndactyly syndrome; Pallister-Hall syndrome; Polysyndactyly 4; Polydactyly, postaxial, type A1 | 2021-11-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003263980 | SCV003953855 | likely benign | Inborn genetic diseases | 2023-05-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |